Back
Sep 28
Education

EDU 03 - Prevention and Management of RT-related Skin Toxicities

02:45pm - 04:00pm PT
Breast Cancer
Nursing and Supportive Care
Palliative Care

MODERATOR(S)

Timur Mitin, MD, PhD - Oregon Health and Science University

session DESCRIPTION

An estimated 90% of patients treated with radiotherapy for breast cancer will develop radiation-induced dermatitis. On the molecular level, radiation upregulates cytokine cascades and fibro-inflammatory pathways, leading to substantial fibrosis, the hallmark of chronic RT damage. Cutaneous fibrosis alters form, function, and aesthetic appearance of the skin, and the consequences can significantly impact quality of life. In this session, the expert physicians - radiation oncologists and dermatologist - will discuss pathophysiology of radiation-induced skin damage and will highlight the techniques to minimize or ameliorate skin toxicities, both acute and long-term. From patient selection, to treatment planning techniques to early detection and evidence-based management of skin toxicities, audience will learn how to apply these techniques in clinical practice to reduce skin toxicities and improve the quality of life of breast cancer patients. Panelists will discuss the use of Mepitel film and topical steroids during breast radiation therapy.

learning objectives

  1. Explain pathophysiology of radiation-induced skin toxicity.
  2. Implement evidence-based management of radiation-induced skin toxicities into clinical practice.
  3. Discuss nuances of patient selection, treatment planning techniques to minimize skin toxicity.

Credits

AMA PRA Category 1 Credits: 1.25

Presentations